Nvidia (NASDAQ:NVDA) has been a darling of the stock market throughout much of 2023. Yet, many traders and even some analysts are highly concerned about NVDA stock now. Still, I encourage investors to stay calm. Irrespective of the perceived headline risk, Nvidia will continue to sell plenty of artificial intelligence (AI) chips in the coming months.
Bankruptcy filings are on the rise. As the economic good times of the past few years are seemingly drawing to a close, it’s creating trouble for many publicly traded companies. This has led to the rise of bankruptcy predictions in this article. Retail companies have been particularly hard hit. Firms such as Bed Bath &
SoFi Technologies (NASDAQ:SOFI) is well known for being among the leading student loan financing companies in the market. However, as I’ve pointed out in recent pieces, SoFi stock is evolving into more than a one-dimensional player. This company is now a one-stop financial solution provider, with a strong focus on student loan refinancing. There’s a
Back in 2020, Wharton finance professor Jeremy Siegel opined that dividend stocks represent the only protection against inflation. Even with tight monetary policies, inflation has remained stubbornly high. To maintain purchasing power of money, it’s important to remain invested in some of the best dividend stocks. Ahead are three dividend growth stocks to buy at
As geopolitical and broad market instabilities heat up, we’ve seen a flight to safety of risk-free assets. The REIT sector has been one of the worst-performing sectors within the S&P 500 in 2023, with higher rates playing a significant role. Certain REITs should be sold in the present market environment of high-interest rates, surging bond
Li Auto (NASDAQ:LI) stock is just the largest of four Chinese electric vehicle names traded in New York. The others are Xpeng (NASDAQ:XPEV), Nio (NYSE:NIO), and Polestar (NASDAQ:PSNY). The last is based in Sweden but controlled by Geely (OTCMKTS:GELYF), a Chinese company. There are others. BYD (OTCMKTS:BYDDF) is the largest, by far, but they’re not
In this article NOVO.B-DK LLY Follow your favorite stocksCREATE FREE ACCOUNT George Frey | Reuters Most analysts predict the market for new weight loss drugs like Wegovy and Mounjaro will be enormous, but estimates vary for its exact size depending on who you ask. On Monday, Citi raised its estimate for incretin drug sales to
Penny stocks can be likened to the crazy world of cryptocurrencies where multibagger returns come at the blink of an eye. As an example, Tilray (NASDAQ:TLRY) stock was trading at $2.5 in March 2020. In a euphoric rally that followed, TLRY stock peaked out at $63.9 in February 2021. More recently, Riot Platforms (NASDAQ:RIOT) stock
The economy appears to be slowing down. Inflation and higher interest rates are proving to be a big drag on the economic outlook. That could make it a rough time for many dividend stocks. The weakness is particularly stark in consumer-facing industries. Bankruptcy filings have been sharply higher in 2023, led by retailers, and that appears to
AMC Entertainment (NYSE:AMC) is one of the most divisive stocks in the market today. On one side, legions of retail investors have passionately bought into the stock, fueling wild price swings and helping it become a poster child of the meme stock phenomenon. Conversely, traditional investors focusing on fundamentals have warned that the company’s deteriorating
Andrew Kelly | Reuters The bond vigilantes are coming back as investors continue to sell amid the prospect of higher-for-longer interest rates and a growing fiscal deficit, according to Kevin Zhao, head of global sovereign and currency at UBS Asset Management. The yield on the benchmark 10-year U.S. Treasury note rose above 5% once again
. The economy is healing as the largest economy in the world experienced its quickest pace of expansion in two years. This all happened during the third quarter. A resilient United States consumer base drove this growth, which poses a challenge for Federal Reserve officials. Officials are debating whether further policy tightening is necessary. During
Interest rates are soaring, the economy faces many challenges and the Federal Reserve remains aggressive in its campaign to stamp out inflation. Amid this uncertainty, investors are turning to dividend stocks for solid income during these worrisome times. However, you should be careful when picking dividend stocks. Not all income yields are created equal. In
Covered call stocks allow investors to earn additional income from their positions. It’s a second dividend, and most publicly traded stocks are eligible for covered calls. You need to own 100 shares to sell a covered call. The seller receives a premium, but is obligated to sell their 100 shares at the designated strike price.
Investing in dividend stocks can be a great way to grow a retirement account. Compounding interest and reinvesting dividends into strong, financially secure companies can lead to an extensive and comprehensive investment portfolio around retirement if investors start dividend investing as early as possible. Every year of investing, especially at a young age, can lead
Understandably, the concept of stocks to sell is a controversial one in the capital market. Let me rephrase that in baseball terms. As a manager, how long are you going to stay with a starting pitcher that just doesn’t have it? When you give up five runs in the first inning? How about 10? What’s
With a few exceptions, healthcare stocks have had a rough go of it in 2023. The Standards and Practices (S&P) 500 Healthcare Index is down 5% year to date, versus a 13% increase in the benchmark S&P 500 index. Most healthcare stocks are down across the board. Pharma companies, health insurers and medical device manufacturers
Biotechnology is the source of some of our strongest and growing revolutions. Gene technology allows us to cure incurable diseases and make miracles happen with living organisms. Immunotherapies promise targeted treatment without harmful side effects. And more and more, we are understanding the deep structure of cancers, allowing us to develop treatments that promise a
Anheuser-Busch InBev (NYSE:BUD) closed its $113 billion acquisition [pg. 45] of SABMiller on Oct. 10, 2016, a little over seven years ago. In that time, BUD stock has lost approximately 58% of its value. In 2015, Anheuser-Busch finished the year with $43.6 billion in revenue, while its normalized profit was $8.5 billion for a respectable
Business is great at Nvidia (NASDAQ:NVDA), but NVDA stock is looking just a bit ragged. For the first time in years, a move up didn’t hit the old high. The August peak of $493/share was followed by an October peak of $469. But even that looks far off from the $429/share it was trading at